Jennifer Kay

10PUBLICATIONS
27CO-AUTHORS
ChemotherapyMolecular targetsPredictive and prognostic markersInstrumental methods (excl. immunological and bioassay methods)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 09, 2026
Guiding Risk Reduction for Breast Cancer-Relevant Chemicals (BC-Chems): Chemical Production Volumes, Sources, Intake Levels, Emissions, and Regulations.

|Jun 25, 2026
Persistent interferon signaling and clonal expansion mark early events in DNA methylation damage-induced liver cancer.

|Nov 19, 2025
Persistent interferon signaling and clonal expansion mark early events in DNA methylation damage-induced liver cancer.

Lee J Pribyl, Jennifer E Kay, Joshua J Corrigan

|Jun 04, 2025
Sex and Alkyladenine DNA Glycosylase Expression are Key Susceptibility Factors for NDMA-induced Mutations, Toxicity, and Cancer.

Jennifer E Kay, Joshua J Corrigan, Lindsay B Volk

|Jan 10, 2024
Application of the Key Characteristics Framework to Identify Potential Breast Carcinogens Using Publicly Available in Vivo, in Vitro, and in Silico Data.

Jennifer E Kay, Julia Green Brody, Megan Schwarzman

|Oct 14, 2022
Novel In Vivo CometChip Reveals NDMA-Induced DNA Damage and Repair in Multiple Mouse Tissues.

Norah A Owiti, Joshua J Corrigan, Lee J Pribyl

Pageof 2

Frequent Collaborators

3 joint publications

Bevin P Engelward

3 joint publications

John M Essigmann

3 joint publications

Lee J Pribyl

3 joint publications

Lindsay B Volk